This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pneumonia Diagnostics Market

Market Insights on Pneumonia Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Pneumonia Diagnostics Market By Product Type (Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based) & Region - Forecast 2017 - 2027

Greater Adoption of Pneumonia Diagnostics Equipment Worldwide

A paradigm shift has been observed from traditional culture diagnosis to rapid pneumonia identification - a game-changer in the pneumonia diagnostics market. In the traditional method, cultures are used to detect pneumonia causative organisms. This is a time-consuming process with a higher error rate when compared to rapid diagnostics. In a few cases such as legionella, culture identification is not readily available and this increases the mortality rate of pneumonia cases caused by it.

The rapid rate of technological advancement has made pneumonia diagnosis much quicker and more cost-effective with a greater degree of sensitivity and specificity. The urinary antigen is an extremely-effective rapid test that allows targeted therapy foe legionnaire at the point-of-care itself.

Customize this Report

Let us know your requirement to get
100% FREE customization

Diagnostic Difficulties Pose a Challenge in Pneumonia Diagnostics Market

It is typically not difficult to diagnose and manage pneumonia in a community seating. Clinical decisions are mainly used in diagnosis information. Nonetheless, there have been some cases with fake positive results that have led to serious patient mismanagement. The patients were prescribed antibiotics and reported super infections and complications because of the former.

Immunoassay techniques seem to be fairly promising for pneumonia diagnostics but are inadequate currently to screen a diverse array of organisms. All of these factors can restrict the growth of the pneumonia diagnostics market and can even decrease adoption in certain situations.

Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market

On account of a rising number of patients contracting pneumonia, the demand for high-quality rapid test kits has seen a noticeable spike. Kits that are fast-acting, have high sensitivity, and specificity is quite high from physicians, hospitals, and diagnostics labs across the world. In addition to this, there is also demand for cost-effective diagnostic kits, particularly in European nations that demand cheaper kits, affluence and higher disposable income notwithstanding.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

North America Largest Region in the Global Pneumonia Diagnostics Market

North America has the largest market share in the pneumonia diagnostics market and should remain so for the duration of the forecast period. The US accounts for more than 4/5th of the North America pneumonia diagnostics market and represents a much larger opportunity than its larger neighbour.

Pneumonia Diagnostics Market Download Report Brochure

However, it would be unwise to ignore Canada entirely as it is poised to witness a higher CAGR of 6.4% for the decade. The intense competition in the North America pneumonia diagnostics market is predicted to cause pricing pressure and key stakeholders will have to take this into account.

 

UK and Germany Critical in Western Europe Pneumonia Diagnostics Market

The UK and Germany accounted for more than 2/5th of the Western Europe pneumonia diagnostics market primarily because of their robust, well-developed healthcare infrastructure and a greater awareness of a geriatric population likely to develop such health issues.

The streptococcus-based product type holds the key to success in the Western Europe pneumonia diagnostics market and companies are recommended to devise their market strategies accordingly. The Western Europe pneumonia diagnostics market is on track to be worth almost US$ 147 million by end 2027.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

APEJ Closely Follows Western Europe in Global Pneumonia Diagnostics Market

APEJ is the third largest region in the pneumonia diagnostics market behind North America and Europe but is unlikely to cross the latter for the foreseeable future. China and India are the countries to keep an eye out for in the APEJ pneumonia diagnostics market. The China pneumonia diagnostics market has a value of approx. US$ 16 million in 2017 itself.

Pneumonia Diagnostics Market Taxonomy

Product Type:

  • Streptococcus-based
  • Legionella-based
  • Chlamydophila-based
  • Viral Pneumonia-based
  • Mycoplasma Pneumonia-based

Region:

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East & Africa 

Frequently Asked Questions

From 2022-2032, the pneumonia diagnostics market is expected to register a CAGR of 6%

By 2022-end, the market for pneumonia diagnostics is expected to reach US$ 1.8 Billion

U.K and Germany will collectively account for over 40% of the pneumonia diagnostics market

By 2032, the pneumonia diagnostics market is expected to reach US$ 3.22 Billion

Table of Content

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Pneumonia Diagnostics  Market View Point

3.1. Macro-Economic Factors

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Trends 

3.3. Opportunity Analysis

3.4. Epidemiology of Pneumonia & Leading Causes of Pneumonia 

4. North America Pneumonia Diagnostics Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.2.1. U.S.

4.2.2. Canada

4.3. Market Size (US$ Mn)  Forecast By Country, 2017-2027

4.3.1. U.S.

4.3.2. Canada

4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

4.4.1. Streptococcus based

4.4.2. Legionella based

4.4.3. Chlamydophila based

4.4.4. Mycoplasma Pneumonia based

4.4.5. Viral Pneumonia based

4.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

4.5.1. Streptococcus based

4.5.2. Legionella based

4.5.3. Chlamydophila based

4.5.4. Mycoplasma Pneumonia based

4.5.5. Viral Pneumonia based

4.6. Drivers and Restraints: Impact Analysis

4.7. Market Attractiveness Analysis

4.7.1. By Country

4.7.2. By Product Type

4.8. Key Representative Market Participants

4.9. Key Participants Market Presence (Intensity Map)

5. Western Europe Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016

5.2.1. Germany

5.2.2. United Kingdom

5.2.3. France

5.2.4. Italy

5.2.5. Spain

5.2.6. Nordics

5.2.7. Rest of Western Europe

5.3. Market Size (US$ Mn) and Volume  Forecast By Country, 2017-2027

5.3.1. Germany

5.3.2. United Kingdom

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Nordics

5.3.7. Rest of Western Europe

5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

5.4.1. Streptococcus based

5.4.2. Legionella based

5.4.3. Chlamydophila based

5.4.4. Mycoplasma Pneumonia based

5.4.5. Viral Pneumonia based

5.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

5.5.1. Streptococcus based

5.5.2. Legionella based

5.5.3. Chlamydophila based

5.5.4. Mycoplasma Pneumonia based

5.5.5. Viral Pneumonia based

5.6. Drivers and Restraints: Impact Analysis

5.7. Market Attractiveness Analysis

5.7.1. By Country

5.7.2. By Product Type

5.8. Key Representative Market Participants

5.9. Key Participants Market Presence (Intensity Map)

6. Eastern Europe Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.2.1. Russia

6.2.2. Poland

6.2.3. Rest of Eastern Europe

6.3. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.3.1. Russia

6.3.2. Poland

6.3.3. Rest of Eastern Europe

6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

6.4.1. Streptococcus based

6.4.2. Legionella based

6.4.3. Chlamydophila based

6.4.4. Mycoplasma Pneumonia based

6.4.5. Viral Pneumonia based

6.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

6.5.1. Streptococcus based

6.5.2. Legionella based

6.5.3. Chlamydophila based

6.5.4. Mycoplasma Pneumonia based

6.5.5. Viral Pneumonia based

6.6. Drivers and Restraints: Impact Analysis

6.7. Market Attractiveness Analysis

6.7.1. By Country

6.7.2. By Product Type

6.8. Key Representative Market Participants

6.9. Key Participants Market Presence (Intensity Map)

7. Latin America Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.2.1. Brazil

7.2.2. Mexico

7.2.3. Rest of Latin America

7.3. Market Size (US$ Mn)  Forecast By Country, 2017-2027

7.3.1. Brazil

7.3.2. Mexico

7.3.3. Rest of Latin America

7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

7.4.1. Streptococcus based

7.4.2. Legionella based

7.4.3. Chlamydophila based

7.4.4. Mycoplasma Pneumonia based

7.4.5. Viral Pneumonia based

7.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

7.5.1. Streptococcus based

7.5.2. Legionella based

7.5.3. Chlamydophila based

7.5.4. Mycoplasma Pneumonia based

7.5.5. Viral Pneumonia based

7.6. Drivers and Restraints: Impact Analysis

7.7. Market Attractiveness Analysis

7.7.1. By Country

7.7.2. By Product Type

7.8. Key Representative Market Participants

7.9. Key Participants Market Presence (Intensity Map)

8. Japan Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Dynamics

8.2.1. Drivers

8.2.2. Restraints

8.2.3. Trends

8.3. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

8.3.1. Streptococcus based

8.3.2. Legionella based

8.3.3. Chlamydophila based

8.3.4. Mycoplasma Pneumonia based

8.3.5. Viral Pneumonia based

8.4. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

8.4.1. Streptococcus based

8.4.2. Legionella based

8.4.3. Chlamydophila based

8.4.4. Mycoplasma Pneumonia based

8.4.5. Viral Pneumonia based

8.5. Drivers and Restraints: Impact Analysis

8.6. Market Attractiveness Analysis

8.6.1. By Product Type

8.7. Key Representative Market Participants

8.8. Key Participants Market Presence (Intensity Map)

9. Asia Pacific Excluding Japan Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

9.2.1. China

9.2.2. India

9.2.3. Australia and New Zealand

9.2.4. ASEAN

9.2.5. Rest of APEJ

9.3. Market Size (US$ Mn) Forecast By Country, 2017-2027

9.3.1. China

9.3.2. India

9.3.3. Australia and New Zealand

9.3.4. ASEAN

9.3.5. Rest of APEJ

9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

9.4.1. Streptococcus based

9.4.2. Legionella based

9.4.3. Chlamydophila based

9.4.4. Mycoplasma Pneumonia based

9.4.5. Viral Pneumonia based

9.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

9.5.1. Streptococcus based

9.5.2. Legionella based

9.5.3. Chlamydophila based

9.5.4. Mycoplasma Pneumonia based

9.5.5. Viral Pneumonia based

9.6. Drivers and Restraints: Impact Analysis

9.7. Market Attractiveness Analysis

9.7.1. By Country

9.7.2. By Product Type

9.8. Key Representative Market Participants

9.9. Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.2.1. GCC Countries

10.2.2. South Africa

10.2.3. Rest of Middle East and Africa

10.3. Market Size (US$ Mn)  Forecast By Country, 2017-2027

10.3.1. GCC Countries

10.3.2. South Africa

10.3.3. Rest of Middle East and Africa

10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

10.4.1. Streptococcus based

10.4.2. Legionella based

10.4.3. Chlamydophila based

10.4.4. Mycoplasma Pneumonia based

10.4.5. Viral Pneumonia based

10.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

10.5.1. Streptococcus based

10.5.2. Legionella based

10.5.3. Chlamydophila based

10.5.4. Mycoplasma Pneumonia based

10.5.5. Viral Pneumonia based

10.6. Drivers and Restraints: Impact Analysis

10.7. Market Attractiveness Analysis

10.7.1. By Country

10.7.2. By Product Type

10.8. Key Representative Market Participants

10.9. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Market Share Analysis

13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

13.2.1. Thermo Fisher Scientific Inc. 

13.2.2. Alere Inc. 

13.2.3. Quidel Corporation 

13.2.4. Becton, Dickinson and Company 

13.2.5. Meridian Bioscience, Inc. 

13.2.6. Qiagen N.V. 

13.2.7. bioMérieux SA

13.2.8. Bio-Rad Laboratories Inc. 

13.2.9. Cardinal Health Inc.

13.2.10. Beckman Coulter Inc (Danaher Corporation)

14. Global Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027 By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) Analysis  By Region, 2012-2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Japan

14.2.6. Asia Pacific Excluding Japan

14.2.7. Middle East and Africa

14.3. Market Size (US$ Mn)  Forecast By Region, 2017-2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Japan

14.3.6. Asia Pacific Excluding Japan

14.3.7. Middle East and Africa

14.4. Market Attractiveness Analysis By Region

15. Global Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type

15.1. Introduction/Key Finding

15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016

15.2.1. Streptococcus based

15.2.2. Legionella based

15.2.3. Chlamydophila based

15.2.4. Mycoplasma Pneumonia based

15.2.5. Viral Pneumonia based

15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027

15.3.1. Streptococcus based

15.3.2. Legionella based

15.3.3. Chlamydophila based

15.3.4. Mycoplasma Pneumonia based

15.3.5. Viral Pneumonia based

15.4. Market Attractiveness Analysis By Product Type

16. Global Pneumonia Diagnostics  Market Analysis 2012–2016 and Forecast 2017–2027

16.1. Market Size and Y-o-Y Growth

16.2. Absolute $ Opportunity

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 03: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 04: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 05: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 06: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 07: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 08: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 09: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 10: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 11: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 12: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 13: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Table 15: Global Pneumonia Diagnostics Market Size (US$ Mn) Forecast by Region, 2012–2017

Table 16: Global Pneumonia Diagnostics Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Pneumonia Diagnostics Market Value (US$ Mn), 2016-2027

Figure 2: Global Pneumonia Diagnostics Market Value Share By Product Type 2016 (A)

Figure 3: Global Pneumonia Diagnostics Market Value Share By Region 2016 (A)

Figure 4 : Leading Cause of Pneumonia based on Epidemiology

Figure 5: North America Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 6: North America Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 7: North America Pneumonia Diagnostics Market Value Share

Figure 8: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 9: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 10: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 11: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 12: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 13: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 14: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 15: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 16: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 17: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 18: North America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 19: North America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 20: North America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 21: North America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 22: Western Europe Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 23: Western Europe Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 24: Western Europe Pneumonia Diagnostics Market Value Share

Figure 25: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 26: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 27: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 28: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 29: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 30: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 31: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 32: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 33: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 34: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 35: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 36: Western Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 37: Western Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 38: Western Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 39: Eastern Europe Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 40: Eastern Europe Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 41: Eastern Europe Pneumonia Diagnostics Market Value Share

Figure 42: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 43: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 44: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 45: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 46: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 47: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 48: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 49: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 50: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 51: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 52: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 53: Eastern Europe Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 54: Eastern Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 55: Eastern Europe Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 56: Latin America Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 57: Latin America Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 58: Latin America Pneumonia Diagnostics Market Value Share

Figure 59: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 60: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 61: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 62: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 63: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 64: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 65: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 66: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 67: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 68: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 69: Latin America Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 70: Latin America Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 71: Latin America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 72: Latin America Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 73: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 74: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 75: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Value Share By End User (2017)

Figure 76: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 77: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 78: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 79: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 80: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 81: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 82: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 83: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 84: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 85: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 86: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 87: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 88: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 89: Asia Pacific Excluding Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 90: Japan Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 91: Japan Pneumonia Diagnostics Market Value Share By End User (2017)

Figure 92: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 93: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 94: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 95: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 96: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 97: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 98: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 99: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 100: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 101: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 102: Japan Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 103: Japan Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 104: Japan Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Product Type

Figure 105: Middle East & Africa Pneumonia Diagnostics Market Value Share By Product Type (2017)

Figure 106: Middle East & Africa Pneumonia Diagnostics Market Value Share By Country (2017)

Figure 107: Middle East & Africa Pneumonia Diagnostics Market Value Share By End User (2017)

Figure 108: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016

Figure 109: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 110: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Streptococcus-based Segment

Figure 111: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Streptococcus-based Segment

Figure 112: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Legionella-based Segment

Figure 113: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Legionella-based Segment

Figure 114: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Chlamydophila-based Segment

Figure 115: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Chlamydophila-based Segment

Figure 116: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Mycoplasma Pneumonia-based Segment

Figure 117: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Mycoplasma Pneumonia-based Segment

Figure 118: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) Analysis, 2012–2016, by Viral Pneumonia-based Segment

Figure 119: Middle East & Africa Pneumonia Diagnostics Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Viral Pneumonia-based Segment

Figure 120: Middle East & Africa Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 121: Middle East & Africa Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Country

Figure 122: Global Pneumonia Diagnostic Market Share Analysis, 2016

Figure 123: Global Pneumonia Diagnostics Market Attractiveness Analysis by Region, 2017–2027 

Figure 124: Global Pneumonia Diagnostics Market Attractiveness Analysis, 2017–2027, by Product Type

Figure 125: Global Pneumonia Diagnostics Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 126: Global Pneumonia Diagnostics Market Absolute $ Opportunity (US$ Mn), 2012–2016

Figure 127: Global Pneumonia Diagnostics Market Absolute $ Opportunity (US$ Mn), 2016–2027

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Pneumonia Diagnostics Market